Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. PT Medikaloka Hermina Tbk's Revenue for the
three
months ended in Jun. 2026 was Rp1,826,203 Mil. PT Medikaloka Hermina Tbk's average Accounts Receivable for the
three
months ended in Jun. 2026 was Rp1,286,329 Mil.
Hence, PT Medikaloka Hermina Tbk's Receivables Turnover for the
three
months ended in Jun. 2026 was 1.42.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
PT Medikaloka Hermina Tbk Receivables Turnover Related Terms
PT Medikaloka Hermina Tbk Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:HEAL vs HCA, THC, EHC: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Receivables Turnover of 1.42 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PT Medikaloka Hermina Tbk and its competitors. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #445 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 67.1%.
Is PT Medikaloka Hermina Tbk's Receivables Turnover too high?
PT Medikaloka Hermina Tbk's current Receivables Turnover is 1.42. The Healthcare Providers & Services industry median Receivables Turnover is 7.97. PT Medikaloka Hermina Tbk's value of 1.42 is 82.2% below this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #445 out of 663 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #445 out of 663 companies for Receivables Turnover. This places PT Medikaloka Hermina Tbk in the lower half of its industry. The industry median Receivables Turnover is 7.97. PT Medikaloka Hermina Tbk's value of 1.42 is 82.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.97, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current Receivables Turnover of 1.42 is 82.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current Receivables Turnover is 1.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,571.00, compared to a current price of Rp665.00 — trading 57.7% below its estimated fair value. The current Receivables Turnover is 1.42 and 82.2% below the Healthcare Providers & Services industry median of 7.97. PT Medikaloka Hermina Tbk's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Receivables Turnover is 1.42 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp665.00 is trading 57.7% below its estimated GF Value™ of Rp1,571.00.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Receivables Turnover: 1.42
GF Value™: Rp1,571.00 vs. price of Rp665.00 (57.7% below fair value)
Industry Position: 82.2% below the Healthcare Providers & Services median (#445 of 663)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
68GF Score
Get the complete analysis for ISX:HEAL
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
